Bruce Jackson
Stock Analyst at Benchmark
(0.92)
# 3,891
Out of 5,182 analysts
116
Total ratings
31.58%
Success rate
-17.85%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Maintains: Speculative Buy | $14 → $10 | $6.65 | +50.38% | 3 | Mar 27, 2026 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $102.38 | +41.63% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.92 | +198.62% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $0.59 | +2,265.26% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $45 → $30 | $5.09 | +489.39% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $4.89 | +574.85% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.56 | +798.44% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $167.25 | -52.17% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $7.75 | - | 8 | Jan 16, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.20 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $7.12 | +321.35% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.30 | +318.62% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $0.55 | +448.05% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.03 | +385.44% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $2.04 | +2,841.18% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $340 | $0.81 | +41,890.86% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.71 | +3,302.81% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $5.38 | -7.06% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.93 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $19.33 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.36 | +33,798.31% | 1 | Aug 8, 2022 |
CapsoVision
Mar 27, 2026
Maintains: Speculative Buy
Price Target: $14 → $10
Current: $6.65
Upside: +50.38%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $102.38
Upside: +41.63%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.92
Upside: +198.62%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $0.59
Upside: +2,265.26%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $45 → $30
Current: $5.09
Upside: +489.39%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $4.89
Upside: +574.85%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.56
Upside: +798.44%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $167.25
Upside: -52.17%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.75
Upside: -
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.20
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $7.12
Upside: +321.35%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.30
Upside: +318.62%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.55
Upside: +448.05%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.03
Upside: +385.44%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $2.04
Upside: +2,841.18%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $340
Current: $0.81
Upside: +41,890.86%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.71
Upside: +3,302.81%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $5.38
Upside: -7.06%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.93
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $19.33
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.36
Upside: +33,798.31%